Cell Therapy Catapult is a centre of translational excellence for cell therapy and regenerative medicine.
Its vision is for the UK to be a global leader in the development, delivery and commercialisation of cell therapy, making it a location for business start-up and growth.
Based in London at Guy's Hospital, the centre takes products into early clinical trials, providing clinical, technical, manufacturing and regulatory expertise and access to the NHS.
There is a focus on collaboration and lowering barriers to investment and funding, and operations have grown rapidly since inception.
UK Trade & Investment has valued the global regenerative medicine industry at just over £500 million, and estimates that it will be generating revenues of over £5 billion by 2021.